Artigo Acesso aberto Revisado por pares

Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes

2019; Springer Nature; Volume: 55; Issue: 3 Linguagem: Inglês

10.1038/s41409-019-0701-3

ISSN

1476-5365

Autores

Pedro Puerta‐Alcalde, Celia Cardozo, Francesc Marco, María Suárez‐Lledó, Estela Moreno-García, Laura Morata, Francesc Fernández‐Avilés, Gonzalo Gutiérrez, Mariana Chumbita, Laura Rosiñol, José Antonio Martínez, Carmen Martı́nez, Josep Mensa, Álvaro Urbano, Montserrat Rovira, Álex Soriano, Carolina García‐Vidal,

Tópico(s)

Antibiotics Pharmacokinetics and Efficacy

Resumo

We aimed to describe epidemiology changes in bloodstream infections (BSI) episodes in hematopoietic stem cell transplant (HSCT) recipients throughout a 25-year period (1993-2017), comparing five-year time spans, and we evaluate their impact on inappropriate empirical antibiotic treatment (IEAT) and mortality. During the study period, 1164 BSI episodes were documented in patients undergoing HSCT (71.6% allogenic and 29% autologous). A significant decrease in gram-positive cocci (GPC) and increase in gram-negative bacilli (GNB) were observed (p < 0.001). Among GP, coagulase-negative staphylococci (CoNS) significantly decreased whereas rising E. faecium BSI was documented. Among GNB, E. coli, Pseudomonas aeruginosa and K. pneumoniae rates increased. Multidrug-resistant (MDR) GNB, especially ESBL-E. coli and MDR-P. aeruginosa, emerged in 2008 and has gradually increased. IEAT against MDR-P. aeruginosa, but not in other MDR-GNB, augmented throughout the study period. Overall, 30-day and related mortality rates were 12.7% and 7.7% respectively, both increasing over time (p < 0.001 and p = 0.025). In GNB, 30-day and related mortality were 18.5% and 12.8%, respectively, increasing over time (p < 0.001 and p = 0.004). To conclude, important BSI epidemiological changes were described in a 25-year period. Concerning increase in IEAT for P. aeruginosa infections and rising 30-day mortality rate were documented.

Referência(s)